Literature DB >> 2592795

A new capillaroscopic assessment of microvascular damage vs Maricq classification in patients with isolated Raynaud phenomenon.

G Arpaia1, C Cimminiello, M Milani, M Aloisio, F Rossi, S B Curri, G Bonfardecci.   

Abstract

A new classification for microvascular lesions assessment by means of capillaroscopy is proposed in this research. The new method, offering a numerical score for microvascular lesions, was used in patients affected by isolated Raynaud Phenomenon (RP). RP can often be associated with scleroderma and, therefore, the new classification has been compared to the Maricq one for what concerns this connective tissue disorder. The numerical method is as sensitive as that by Maricq, but, as easily expected, its specificity is quite low. It appeared to be satisfactory also the positive predictive value of the new capillaroscopy classification combination with the clinical examination and with the immunologic biohumoral investigation. It is particularly easy to apply this method, as it presents to the examinator a restricted range of answers, for the capillaroscopic picture description, but it needs further studies in different microcirculation damages to be proved definitely valuable.

Entities:  

Mesh:

Year:  1989        PMID: 2592795

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  3 in total

Review 1.  Acrocyanosis: the Flying Dutchman.

Authors:  Andrew K Kurklinsky; Virginia M Miller; Thom W Rooke
Journal:  Vasc Med       Date:  2011-03-22       Impact factor: 3.239

2.  Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study.

Authors:  P Zufferey; M Depairon; A M Chamot; M Monti
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

3.  Office capillaroscopy in systemic sclerosis.

Authors:  Murray Baron; Mary Bell; Arthur Bookman; Maura Buchignani; James Dunne; Marie Hudson; Dana Jerome; Sindhu R Johnson; Niall Jones; Elzbieta Kaminska; Terri Lupton; Jean-Pierre Mathieu; Janet Pope; Russell Steele; Suzanne Taillefer
Journal:  Clin Rheumatol       Date:  2006-12-09       Impact factor: 3.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.